From Rs 32.50 cr to Rs 37.50 cr
Sun Pharma Advanced Research Company announced that it received shareholders approval on 30 September 2020 for increase in authorized share capital of the company from the present Rs. 32,50,00,000/- divided into 32,50,00,000 Equity Shares of Re. 1/- each to Rs. 37,50,00,000/- divided into 37,50,00,000 Equity Shares of Re. 1/- each.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
